Director Hal Kravitz bought 8,400 CELH shares at $29.73; stock down 55.5% from $66.74 high, part of 2-insider cluster buy.
Hal Kravitz, a Director, purchased 8,400 shares at $29.73 on 2026-05-22, expanding his CELH holdings from 218.8K to 227.2K shares. The stock currently trades at $29.67, down 55.5% from its 52-week high of $66.74 and down 41.4% over the past 90 days. At the same-ticker level, Kravitz's prior buy on 2025-11-13 returned -2.0% over 90 days, while his two prior sales at CELH (2024-05-14 and 2023-12-06) posted -57.9% and unmeasured outcomes respectively. A cluster pattern is present: 2 other insiders also bought within the past 14 days. Fundamentals show robust revenue growth of 85.5% annually and a net income of $110.1M against revenue of $782.6M, though the P/E of 43.63 and market cap of $7.6B reflect the stock's elevated valuation relative to current earnings.
Director Hal Kravitz purchased 10,000 CELH shares at $45.24 on 2025-11-13, now trading at $40.16 (-38.1% from high).
Hal Kravitz, a director at Celsius Holdings, acquired 10,000 shares (10.0K shares) at $45.24, increasing his stake to 216,147 shares (216.1K shares). The stock has since declined to $40.16, representing a -38.1% move from its 52-week high of $64.86. Notably, Kravitz's cross-ticker track record shows 2 prior sells with a 90-day well-timed rate of 100.00%, suggesting a history of selling before declines; his same-ticker history at CELH includes a May 2024 sell that preceded a -57.9% 90-day decline. The purchase occurs in a deteriorating fundamental backdrop: CELH reported net income of $-61.0M against revenue of $725.1M (annual growth only +2.8%), with a P/E ratio of 160.64. This buy follows the insider's proven ability to time exits but does not offset the underlying weakness in profitability and valuation multiples.